GSK Investigational Site

Newport Beach, California 92663

We've found

2 trials

at this facility

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Newport Beach, CA

First Time in Humans (FTIH) Study of GSK3368715 in Subjects With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Newport Beach, CA

Use our guide to learn which trials are right for you!